Low-dose oral or non-oral hormone therapy: effects on C-reactive protein and atrial natriuretic peptide in menopause

Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease

(2013) Raouf A. Khalil   BIOCHEMICAL PHARMACOLOGY

Weight gain and abdominal obesity at menopause

(2013) P. M. Spritzer et al.   CLIMACTERIC

Hormone replacement therapy and the association with coronary heart disease and overall mortality: Clinical application of the timing hypothesis

(2013) Howard N. Hodis et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

The Women's Health Initiative trial and related studies: 10 years later: A clinician's view

(2013) Elizabeth P. Gurney et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Timing hypothesis for postmenopausal hormone therapy

(2013) Thomas B. Clarkson et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Effects of Estrogen on Vascular Inflammation

(2012) Susana Novella et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Endogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition

(2012) Samar R. El Khoudary et al.   ATHEROSCLEROSIS

Understanding weight gain at menopause

(2012) S. R. Davis et al.   CLIMACTERIC

Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial

(2012) Gislaine Casanova et al.   Lipids in Health and Disease

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

(2012) L. L. Schierbeck et al.   BMJ-British Medical Journal

Concept of Vulnerable/Unstable Plaque

(2010) Aloke V. Finn et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Clinical and metabolic effects of drospirenone–estradiol in menopausal women: a prospective study

(2010) M. Gambacciani et al.   CLIMACTERIC

Oral ultra-low dose continuous combined hormone replacement therapy with 0.5mg 17β-oestradiol and 2.5mg dydrogesterone for the treatment of vasomotor symptoms: Results from a double-blind, controlled study

(2010) John C. Stevenson et al.   MATURITAS

Lipid Changes During the Menopause Transition in Relation to Age and Weight: The Study of Women's Health Across the Nation

(2009) C. A. Derby et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Usefulness of Baseline Lipids and C-Reactive Protein in Women Receiving Menopausal Hormone Therapy as Predictors of Treatment-Related Coronary Events

(2008) Paul F. Bray et al.   AMERICAN JOURNAL OF CARDIOLOGY

Inflammatory, Lipid, Thrombotic, and Genetic Markers of Coronary Heart Disease Risk in the Women's Health Initiative Trials of Hormone Therapy

(2008) Jacques E. Rossouw et al.   ARCHIVES OF INTERNAL MEDICINE

Effects of nonoral estradiol–micronized progesterone or low-dose oral estradiol–drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause

(2008) Gislaine Casanova et al.   FERTILITY AND STERILITY

A Comparison of the Short-Term Effects of Oral Conjugated Equine EstrogensVersusTransdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women

(2008) Jan L. Shifren et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Impairment of the Natriuretic Peptide System in Follitropin Receptor Knockout Mice and Reversal by Estradiol: Implications for Obesity-Associated Hypertension in Menopause

(2007) Najara O. Belo et al.   ENDOCRINOLOGY